• Arachidonic Acid and Vaccine-Induced Humoral Immunity

  2026-08-14

  The reference study reports that dietary arachidonic acid accelerates rabies vaccine-induced neutralizing antibody responses in mice and human volunteers. Its mechanistic model links lymph-node arachidonate metabolism, prostaglandin I2 signaling, CD86 expression, and activation-induced cytidine deaminase in B cells, suggesting a potential dietary route for strengthening germinal-center immunity.

• AG-490: Reading JAK2/STAT6 in HCC

  2026-08-13

  AG-490 (Tyrphostin B42) provides a practical pharmacological lens for studying exosomal SNORD52, JAK2/STAT6 signaling, and macrophage polarization in hepatocellular carcinoma. This article translates recent mechanistic findings into better assay design, target interpretation, and experimental controls.

• Peroxynitrite, Ca2+ Flux, and Cardiac Necroptosis

  2026-08-13

  Liu et al. identify a mechanistic pathway in which hyperhomocysteinemia intensifies cardiac microvascular ischemia–reperfusion injury through peroxynitrite-driven ER stress, IP3R-dependent Ca2+ transfer, mitochondrial overload, and CMEC necroptosis. Their cell and rat models connect a metabolic cardiovascular risk factor to endothelial microvascular failure and show that IP3R inhibition improves cardiac injury outcomes.

• MDM1, p53, and Chemoradiotherapy Sensitivity in CRC

  2026-08-13

  The reference study identifies MDM1 as a potential colorectal cancer chemoradiotherapy-sensitivity marker and connects its activity to p53 regulation and apoptosis. Its integrated genetic, transcriptomic, mechanistic, and xenograft evidence suggests that MDM1 status could help explain treatment response, although clinical validation remains necessary.

• AMD-070 Hydrochloride: CXCR4 Assay Design

  2026-08-12

  AMD-070 hydrochloride enables controlled CXCR4 antagonism in migration, hematologic, and anti-HIV research. This article develops a perfusion-aware assay framework, using an ischemia–reperfusion study to show how orthogonal readouts can distinguish receptor-specific biology from tissue-level confounding.

• Hematoxylin and Eosin Staining Kit Guide

  2026-08-11

  The Hematoxylin and Eosin Staining Kit (SKU K1142) provides ready-to-use hematoxylin and eosin solutions for visualizing cellular and tissue morphology in sections and cytological preparations. It is suitable for research workflows involving paraffin, frozen, or cytology samples, but it should not be used as a diagnostic or medical test without separate validation.

• Tp47, PKM2, and Inflammatory Senescence

  2026-08-11

  A December 2024 study shows that the Treponema pallidum protein Tp47 drives macrophage inflammatory senescence through PKM2 stabilization, glycolytic reprogramming, lactate signaling, and EIF2AK2-linked pyroptosis. The work connects pathogen persistence with immunometabolic control and identifies assay and intervention points for studying senescent macrophage phenotypes.

• Hydroxychloroquine Sulfate Workflow Guide

  2026-08-10

  Hydroxychloroquine Sulfate provides an aqueous-compatible research reagent for probing autophagy pathway modulation and TLR7/9-dependent immune activation in autoimmune disease research. It is best suited to freshly prepared, short-term water-based workflows and should not be selected for protocols requiring DMSO or ethanol solubility or prolonged solution storage.

• Nirmatrelvir: From Protease Biology to Assay Evidence

  2026-08-09

  Nirmatrelvir (PF-07321332) offers a mechanistically defined way to study SARS-CoV-2 polyprotein processing and replication. This guide connects protease structure, docking evidence, physicochemical handling, and orthogonal assay design for stronger antiviral therapeutics research.

• Heterologous Regulators Boost A40926 Production

  2026-08-08

  The 2024 study shows that StrR-like regulatory proteins from distantly related antibiotic biosynthetic clusters can alter production of teicoplanin and A40926 when expressed in heterologous actinobacterial hosts. Its most important finding is that Chers28, but not Ramo5, improved glycopeptide output, revealing both the promise and selectivity of regulator-mediated pathway engineering.

• Spleen-Targeted mRNA Vaccine Builds TLS in HCC

  2026-08-07

  Lin et al. developed a spleen-targeted neoantigen mRNA vaccine that generated neoantigen-specific ISG15+ CD8+ T cells and promoted tertiary lymphoid structure formation in hepatocellular carcinoma. The study connects organ-selective delivery with a GZMA–F2R immune-cell interaction, offering a mechanistic framework for improving preclinical RNA vaccine development while leaving important translational questions unresolved.

• Resiniferatoxin (RTX): Strategic Leverage in Translational P

  2026-08-07

  This thought-leadership article explores Resiniferatoxin (RTX) as a disruptive tool for precise, long-lasting TRPV1 inactivation, blending mechanistic insight with practical strategy for translational and preclinical researchers. It synthesizes recent advances in TRPV1 biology, competitive modalities, and workflow protocols, offering actionable guidance and a forward-looking vision for pain and inflammation research.

• Targeted Removal of Senescent Beta Cells Prevents Type 1 Dia

  2026-08-06

  Thompson et al. (2019) reveal that senescent beta cells accumulate during the development of type 1 diabetes (T1D) and actively contribute to disease progression by acquiring a pro-inflammatory secretory phenotype. The study demonstrates that selective elimination of these senescent cells using Bcl-2 inhibitors halts beta cell loss and prevents diabetes onset, highlighting a new therapeutic strategy for T1D intervention.

• In Vitro Activity of Midecamycin Against Pathogenic Bacteria

  2026-08-06

  This study systematically evaluates midecamycin, a novel macrolide antibiotic, for its in vitro efficacy against a spectrum of gram-positive and gram-negative bacteria. The research delineates midecamycin’s activity profile, methodological rigor, and comparative potency, offering essential context for antibacterial agent selection and resistance studies.

• HLY78 in Hematopoietic Stem Cell Induction: Beyond Wnt Modul

  2026-08-05

  Discover how HLY78, a powerful Wnt/β-catenin pathway modulator, enables precise induction of hematopoietic stem cell markers in embryonic development models. This article uniquely unpacks the mechanistic nuances, translational workflow considerations, and emerging assay guidance that set HLY78 apart for advanced research applications.

452 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page